NovoCure (NVCR) Receivables - Net (2014 - 2026)
NovoCure (NVCR) posted Receivables - Net of $99.1 million for Q2 2026, up 6.28% sequentially from $93.3 million in Q1 2026, and up 10.25% YoY from $89.9 million in Q2 2025.
NovoCure (NVCR) Receivables - Net (2014 - 2026) Analysis & Trends
NovoCure has reported Receivables - Net for 13 years, with the latest figure at $99.1 million in Q2 2026.
- Quarterly Receivables - Net rose 10.25% year-over-year to $99.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $99.1 million (up 10.25% YoY) and the FY2025 annual result came in at $89.4 million, up 20.49% from the prior year.
- Receivables - Net improved to $99.1 million in Q2 2026 per NVCR's latest filing, from $93.3 million in the prior quarter.
- Over five years, Receivables - Net peaked at $101.0 million in Q1 2022 and troughed at $22.7 million in Q4 2023.
- A 5-year average of $74.9 million and a median of $79.7 million in 2023 frame the typical range for Receivables - Net.
- The sharpest annual moves came in 2022 and 2023: Receivables - Net jumped 406.67% in 2022, then sank 73.71% in 2023.
- Over 5 years, Receivables - Net stood at $86.3 million in 2022, then tumbled by 73.71% to $22.7 million in 2023, then surged by 54.62% to $35.1 million in 2024, then soared by 67.32% to $58.7 million in 2025, then jumped by 68.97% to $99.1 million in 2026.
- According to Business Quant data, Receivables - Net over the past three periods registered $99.1 million, $93.3 million, and $58.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | NovoCure | 2.06 Bn | 1.62 Bn | 142.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 99.13 Mn |
| Jun 30, 2026 | 99.13 Mn |
| Mar 31, 2026 | 93.27 Mn |
| Mar 31, 2026 | 93.27 Mn |
| Dec 31, 2025 | 58.67 Mn |
| Dec 31, 2025 | 58.67 Mn |
| Sep 30, 2025 | 85.23 Mn |
| Sep 30, 2025 | 85.23 Mn |
| Jun 30, 2025 | 89.92 Mn |
| Jun 30, 2025 | 89.92 Mn |
| Mar 31, 2025 | 84.51 Mn |
| Mar 31, 2025 | 84.51 Mn |
| Dec 31, 2024 | 35.06 Mn |
| Dec 31, 2024 | 35.06 Mn |
| Sep 30, 2024 | 67.06 Mn |
| Sep 30, 2024 | 67.06 Mn |
| Jun 30, 2024 | 64.70 Mn |
| Jun 30, 2024 | 64.70 Mn |
| Mar 31, 2024 | 65.09 Mn |
| Mar 31, 2024 | 65.09 Mn |